🕵️ Eledon Pharmaceuticals, Inc. ($ELDN)
SEC insider & ownership activity, last 12 months · CIK 1404281 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. BlackRock, Inc. added 5.4% → 5.8%. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BVF Partners L P/IL | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| BVF INC/IL | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Mark N. Lampert | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| BVF GP Holdings LLC | 9.4% | 13G | May 15, 2026 | filing ↗ | |
| Biotechnology Value Fund L P | 6.8% | 13G | May 15, 2026 | filing ↗ | |
| BVF I GP LLC | 6.8% | 13G | May 15, 2026 | filing ↗ | |
| BlackRock, Inc. | 5.8% | 13G | Apr 27, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.0% | 13G | Jul 31, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 18, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 18, 2026 | filing ↗ |
| Earnings (2.02) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Earnings (2.02) | Mar 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 19, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Dec 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 30, 2025 | filing ↗ |
| Earnings (2.02) | Nov 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing ↗ |
| Material agreement (1.01) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |